Candida auris Invasive Infections during a COVID-19 Case Surge
- PMID: 34339274
- PMCID: PMC8448104
- DOI: 10.1128/AAC.01146-21
Candida auris Invasive Infections during a COVID-19 Case Surge
Abstract
Clinical cases of C. auris noted during a COVID-19 surge led to an epidemiological, clinical, and genomic investigation. Evaluation identified a close genetic relationship but inconclusive epidemiologic link between all cases. Prolonged hospitalization due to critical illness from COVID-19 and use of antimicrobials may have contributed to clinical infections.
Keywords: COVID-19; Candida auris; outbreak investigation; whole-genome sequencing.
Figures
References
-
- Falcone M, Tiseo G, Giordano C, Leonildi A, Menichini M, Vecchione A, Pistello M, Guarracino F, Ghiadoni L, Forfori F, Barnini S, Menichetti F, O Degl’Innocenti SA, Barbieri G, Biancalana M, Borselli M, Nencini E, Spinelli S, Antognoli R, Calsolario V, Monzani F, Paterni S, Baldassarri R, Bertini P, Brizzi G, Rocca AD, Malacarne P, Monfroni M, Piagnani C, Carpenè N, Carrozzi L, Celi A, Desideri M, Gherardi M, Serradori M, Cinotti F, Cipriano A, Park N, Forotti G, Mengozzi A, Masi S, Ruberti F, Sciuto M, Virdis A, Maggi F, Galfo V, The Pisa COVID-19 Study Group . 2021. Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study. J Antimicrob Chemother 76:1078–1084. 10.1093/jac/dkaa530. - DOI - PMC - PubMed
-
- CDC. 2019. Antibiotic resistance threats in the United States. U.S. Department of Health and Human Services, Atlanta, GA. https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-re.... Accessed 20 February 2021.
-
- van Duin D, Arias CA, Komarow L, Chen L, Hanson BM, Weston G, Cober E, Garner OB, Jacob JT, Satlin MJ, Fries BC, Garcia-Diaz J, Doi Y, Dhar S, Kaye KS, Earley M, Hujer AM, Hujer KM, Domitrovic TN, Shropshire WC, Dinh A, Manca C, Luterbach CL, Wang M, Paterson DL, Banerjee R, Patel R, Evans S, Hill C, Arias R, Chambers HF, Fowler VG, Kreiswirth BN, Bonomo RA, Multi-Drug Resistant Organism Network Investigators . 2020. Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the United StatesA (CRACKLE-2): a prospective cohort study. Lancet Infect Dis 20:731–741. 10.1016/S1473-3099(19)30755-8. - DOI - PMC - PubMed
-
- Shropshire WC, Aitken SL, Pifer R, Kim J, Bhatti MM, Li X, Kalia A, Galloway-Peña J, Sahasrabhojane P, Arias CA, Greenberg DE, Hanson BM, Shelburne SA. 2021. IS26-mediated amplification of blaOXA-1 and blaCTX-M-15 with concurrent outer membrane porin disruption associated with de novo carbapenem resistance in a recurrent bacteraemia cohort. J Antimicrob Chemother 76:385–395. 10.1093/jac/dkaa447. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AI134637/AI/NIAID NIH HHS/United States
- K24AI121296/HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- K24 AI121296/AI/NIAID NIH HHS/United States
- K01AI148593/HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- P01 AI152999/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
